IPPOSI contributes to emerging health policies both voluntarily, and at the reqest of the Department of Health, HIQA, the HSE and other state agencies. In recent years IPPOSI has made submissions and/or facilitated membership engagement across a range of areas, including:
- IPPOSI response to the Public Consultation for the WHO Guidance for Best Practices for Clinical Trials – September 2023
- IPPOSI response to the Department of Health Mazars Report Stakeholder Consultation – June 2023
- IPPOSI response to the Department of Health Consultation Survey on the draft Patient Voices Partner (PVP) Policy – February 2023
- IPPOSI Patient Members’ response to the Department of Health Consultation on the draft Patient Voices Partner (PVP) Policy – February 2023
- IPPOSI response to HIQA Draft National Standards for Information Management in Health and Social Care – December 2022
- IPPOSI response to the Nursing and Midwifery Board of Ireland public consultation on Statement of Strategy – September 2022
- IPPOSI response to DHFERIS public consultation on Scientific Advice – September 2022
- IPPOSI response to the EUnetHTA 21 Public Consultation – August 2022
- IPPOSI response to the adoption by the European Parliament of a new regulation on Health Technology Assessment (HTA) – January 2022
- IPPOSI response to the HIQA Draft Recommendations on a consent model for the collection, use, and sharing of health information in Ireland – January 2022
- IPPOSI response to the European Commission public consultation on the revision of the general pharmaceutical legislation – December 2021
- IPPOSI response to the European Commission consultation on the European Health Data Space – July 2021
- IPPOSI response to the EU public consultation on The Revision of EU Rules on Medicines for Children and Rare Diseases – July 2021
- IPPOSI response to the Department of Further and Higher Education, Research, Innovation and Science consultation on the National Research and Innovation Strategy for 2021-2027 – July 2021
- IPPOSI recommendations for the re-negotiation of the IPHA-Dept-of-Health-HSE agreement – May 2021
- IPPOSI response to request from Joint Oireachtas Committee on Disability Matters for a submission in relation to COVID-19 Vaccination plan – Jan 2021
- IPPOSI response to HIQA recommendations to the Minister for Health on a National Patient Summary – Sept 2020
- IPPOSI response to the European Commission consultation on the future Pharmaceutical Strategy – Sept 2020
- IPPOSI submission to the Joint Oireachtas Committee on Health, Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2013 – April 2019
- IPPOSI response to NCPE consultation on the Patient Submission Template – May 2018
- IPPOSI response to HIQA National Patient Summary – May 2018
- IPPOSI response to Irish Pharmacy Union public consultation on e-prescribing – April 2018
- IPPOSI response to HIQA consultation on HTA guidelines – November 2017
- HIQA Guidelines for Economic Evaluation and Budget Impact Analysis – IPPOSI first submission – November 2017
- IPPOSI Consultation Response on the Draft Health Information Policy Framework – November 2017
- IPPOSI Response to public consultation on National Biosimilars Policy – September 2017
- IPPOSI submission to the Oireachtas Health Committee on the Health Information Bill & Patient Safety Bill (pre-legislative stage) – January 2017
- IPPOSI submission to the Oireachtas Committee on the Future of Healthcare – September 2016
- Response to Individual Health Identifier Public Consultation – March 2016
- IPPOSI Board response to the draft Privacy Impact Assessment for IHI – July 2015
- Strategy for Science, Technology & Innovation – March 2015
- Universal Health Insurance White Paper – May 2014
- EU Public Consultation Rare Diseases: EUROPE’S CHALLENGES – 2008
- EC PUBLIC CONSULTATION: Legal Proposal on Information to Patients – 2008
- IPPOSI Submission to the Department of Health and Children: Discussion Paper on Proposed Health Information Bill – 2008